Current Report Filing (8-k)
March 16 2015 - 1:38PM
Edgar (US Regulatory)
|
UNITED STATES |
SECURITIES AND EXCHANGE COMMISSION |
Washington, D.C. 20549 |
|
|
FORM 8-K |
|
|
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934 |
|
|
Date of Report (Date of the earliest event reported)
March 13, 2015 |
|
|
|
ULTRALIFE CORPORATION |
(Exact name of registrant as specified in its charter) |
|
|
|
Delaware |
000-20852 |
16-1387013 |
(State of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
|
2000
Technology Parkway, Newark, New York |
14513 |
(Address of principal executive offices) |
(Zip Code) |
|
(315) 332-7100 |
(Registrant’s telephone number, including area code) |
|
|
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): |
|
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
|
|
|
|
|
Item
8.01 Other Events
As previously disclosed, on April 28, 2014 Ultralife Corporation’s Board of Directors approved a share
repurchase program that became effective on May 1, 2014. On March 13, 2015, the Company adopted a written trading plan under Rule
10b5-1 of the Securities and Exchange Act of 1934, as amended. The Company may utilize this plan to make purchases of its common
stock through April 30, 2015, the expiration date of its share repurchase program, and covering a period during which it would
otherwise be subject to a self-imposed trading blackout. Repurchases under the previously announced repurchase plan and the trading
plan are subject to the Securities and Exchange Commission’s regulations as well as certain price, market, volume and timing
constraints specified in the plans.
SIGNATURES
Pursuant to the requirements of the Securities Exchange
Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
|
ULTRALIFE CORPORATION |
|
|
March
16, 2015 |
By: |
/s/
Philip A. Fain |
|
|
Chief Financial
Officer and Treasurer |
Ultralife (NASDAQ:ULBI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Ultralife (NASDAQ:ULBI)
Historical Stock Chart
From Apr 2023 to Apr 2024